Загрузка...
Randomized study of continuous high-dose lenalidomide, sequential azacitidine and lenalidomide, or azacitidine in persons 65 years and over with newly-diagnosed acute myeloid leukemia
Therapy of acute myeloid leukemia in older persons is associated with poor outcomes because of intolerance to intensive therapy, resistant disease and co-morbidities. This multi-center, randomized, open-label, phase II trial compared safety and efficacy of three therapeutic strategies in patients 65...
Сохранить в:
| Опубликовано в: : | Haematologica |
|---|---|
| Главные авторы: | , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Ferrata Storti Foundation
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5777197/ https://ncbi.nlm.nih.gov/pubmed/29097499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2017.172353 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|